TriSalus Life Sciences, Inc.

MedTech Acquisition Corp, trading under the ticker MTAC, was a healthcare and medical technology focused special purpose acquisition company that completed its initial public offering in 2021, sponsored by MedTech Acquisition Sponsor LLC. On December 13, 2021, the company filed a 10-Q/A, an amended quarterly report, with the SEC under the TriSalus Life Sciences, Inc. entity name, reflecting activity during the SPAC's active deal process in the medtech and oncology sector. TriSalus Life Sciences, which develops targeted drug delivery systems for oncology applications, ultimately completed its business combination with MTAC. For full filing history, sponsor disclosures, and deal timeline data on MTAC and hundreds of other SPACs, sign up for SpacDesk at spacdesk.com.